TELDRIN Drug Patent Profile
When do Teldrin patents expire, and when can generic versions of Teldrin launch?
Teldrin is a drug marketed by Glaxosmithkline and is included in one NDA.
The generic ingredient in TELDRIN is chlorpheniramine maleate. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the chlorpheniramine maleate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Teldrin
A generic version of TELDRIN was approved as chlorpheniramine maleate by AVANTHI INC on May 13th, 2009.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TELDRIN?
- What are the global sales for TELDRIN?
- What is Average Wholesale Price for TELDRIN?
Summary for TELDRIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 56 |
| Patent Applications: | 4,636 |
| DailyMed Link: | TELDRIN at DailyMed |
US Patents and Regulatory Information for TELDRIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaxosmithkline | TELDRIN | chlorpheniramine maleate | CAPSULE, EXTENDED RELEASE;ORAL | 017369-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Glaxosmithkline | TELDRIN | chlorpheniramine maleate | CAPSULE, EXTENDED RELEASE;ORAL | 017369-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
